MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00259-025-07674-5

Медицинская библиотека · European journal of nuclear medicine and molecular imaging · 2025

Potential value of [68Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis.

Pabst Kim M, Siegmund Sophie C, Holzgreve Adrien, Schmid Hans P, Bartel Timo, Herrmann Ken, Küper Alina T, Aydogdu Can, Kersting David, Kesch Claudia, Hadaschik Boris A, Unterrainer Marcus, Stief Christian G, Cyran Clemens C, Werner Rudolf A, Fendler Wolfgang P, Casuscelli Jozefina, Unterrainer Lena M

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

PURPOSE: [68Ga]Ga-FAPI-46 has shown promise for urothelial cancer (UC) detection. This study evaluates its diagnostic value versus contrast-enhanced CT (ceCT) and 2-[18F]FDG PET in the largest bi-centric cohort to date.

METHODS

Patients with metastatic UC undergoing [68Ga]Ga-FAPI-46 PET at University Hospitals Munich or Essen were retrospectively reviewed. Detection rates were compared with ceCT on a regional basis (primary, lymph nodes, visceral organs, bone). SUVmax and SUVmean of two index lesions were recorded. In a sub-cohort, [68Ga]Ga-FAPI-46 and 2-[18F]FDG PET were compared on a lesion basis. Clinical follow-up and/or histopathology served as reference.

RESULTS

Thirty-four patients underwent [68Ga]Ga-FAPI-46 PET/CT and ceCT, including 10 (29%) with additional 2-[18F]FDG PET/CT. Across 98 lesions (n = 65 regions), [68Ga]Ga-FAPI-46 PET detected n = 96 (98%) and ceCT n = 88 (90%), with mismatch findings in eight lymph nodes (PET positive/ceCT negative) and two visceral organs (ceCT positive/PET negative). In the subgroup comparison, 78 lesions were detected in total ([68Ga]Ga-FAPI-46: n = 72 (92%); 2-[18F]FDG: n = 78 (100%)). Tumour uptake was comparable (SUVmax [68Ga]Ga-FAPI-46 PET vs. 2-[18F]FDG: 10.2 (IQR, 1.9) vs. 8.0 (IQR, 3.3), p = 0.249), whereas [68Ga]Ga-FAPI-46 provided higher tumour-to-background ratios (Tumour-to-liver: 12.7 (IQR, 10.3) vs. 3.8 (IQR, 1.9), p = 0.046; tumour-to-spleen: 8.4 (IQR, 6.6) vs. 4.6 (IQR, 0.6), p = 0.016).

CONCLUSION

[68Ga]Ga-FAPI-46 PET demonstrated higher regional detection rates than ceCT in UC patients, particularly for lymph node metastases. Compared to 2-[18F]FDG, it provided superior tumour-to-background contrast but detected slightly fewer lesions. [68Ga]Ga-FAPI-46 PET may complement established imaging in selected scenarios, although its role in routine UC staging remains investigational.

Для цитирования: Pabst Kim M, Siegmund Sophie C, Holzgreve Adrien, Schmid Hans P, Bartel Timo, Herrmann Ken, Küper Alina T, Aydogdu Can, Kersting David, Kesch Claudia, Hadaschik Boris A, Unterrainer Marcus, Stief Christian G, Cyran Clemens C, Werner Rudolf A, Fendler Wolfgang P, Casuscelli Jozefina, Unterrainer Lena M. Potential value of [68Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis.. European journal of nuclear medicine and molecular imaging. 2025. DOI: 10.1007/s00259-025-07674-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.